PMPrabhu Manivannan

Prabhu Manivannan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Prabhu Manivannan has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genome-Wide DNA Methylation Landscape in Indian Paediatric B-Cell Acute Lymphoblastic Leukaemia and Candidate Methylation Differences Associated with Post-Induction Measurable Residual Disease: An Exploratory Study

    by Ramya Ramesh, Sagar Desai, Aazim Hashmi, Amit Choudhary, Prashant Adole, Prabhu Manivannan, Prasanth Ganesan, Jayanthi Mathaiyan, Biswajit Dubashi, Bibha Choudhary, et al.

    DNA methylation at diagnosis may help explain variable treatment response in paediatric B-cell acute lymphoblastic leukaemia (B-ALL), but genome-wide data from Indian patients are lacking. In this exploratory study, we performed whole-genome bisulphite sequencing on baseline peripheral blood from eight treatment-naive paediatric B-ALL patients, four with and four without post-induction measurable residual disease (MRD), and four healthy paediatric controls (peripheral blood mononuclear cell DNA). Differentially methylated regions (DMRs), co-methylation modules, pathway-level methylation and methylome-wide associations with clinical variables were analysed, and candidate genes were examined in an independent B-ALL expression dataset. B-ALL methylomes were more heterogeneous than those of controls (74.7–85.7% vs. 81.5–82.9% CpG methylation). MRD-positive patients showed more hypermethylated than hypomethylated DMRs (18,684 vs. 12,331). APEX1 promoter hypermethylation was observed in all four MRD-positive patients, but APEX1 expression did not differ by MRD status in an external paediatric B-ALL RNA-seq cohort (n = 70; p = 0.46), so this remains a preliminary candidate. In external B-ALL expression data, genome-wide methylation–expression concordance was close to chance (45–53%), although selected genes such as DNTT were hypomethylated and strongly upregulated. These exploratory, hypothesis-generating data do not establish that baseline methylation predicts MRD or outcome; they provide a baseline methylome resource for Indian paediatric B-ALL and candidate loci for validation in larger, subtype-balanced cohorts.

  • Open Access

    Can leukemic stem cells predict short-term outcome in acute myeloid leukemia? – A prospective cohort study from India

    by Visaali Sivakumar, Prabhu Manivannan, Smita Kayal

    Objectives: Acute myeloid leukemia (AML) is a clonal stem cell disorder with impaired differentiation, myeloblast proliferation, and genetic heterogeneity. Although remission is frequently achieved with induction therapy, relapse remains common, partly attributed to therapy-resistant leukemic stem cells (LSCs). Indian data on the prognostic significance of LSCs are limited. This study aimed to quantify LSCs at diagnosis using multicolor flow cytometry (MFC) and evaluate their association with clinico-hematological features and response to induction therapy. Materials and Methods: This prospective cohort study (September 2022–January 2024) included newly diagnosed AML patients aged <65 years, excluding therapy-related AML, antecedent myelodysplastic neoplasm, and acute promyelocytic leukemia. Clinical parameters and bone marrow samples were analyzed, and LSCs were quantified by MFC. Eighty-six patients were enrolled, with approximately 40% evaluable for post-induction response. Statistical analysis: Receiver operating characteristic curves identified optimal LSC thresholds. Associations were assessed using Mann–Whitney/Kruskal–Wallis and Fisher’s exact tests. Survival was evaluated using Kaplan– Meier analysis with log-rank testing, and prognostic factors using backward stepwise Cox regression. Results: The median LSC percentage was 4.5% (range: 0.01–89%). A cutoff of 1% showed high sensitivity but low specificity for predicting remission and induction mortality. LSC% correlated with CD34 expression and abnormal karyotype but not with remission, induction mortality, or overall survival (OS) (median OS: 5.5 months). Age, karyotype, and European LeukemiaNet-2022 risk category were significant prognostic factors. Conclusions: LSCs did not predict short-term outcomes in AML; established clinical and genetic factors remained more reliable prognostic indicators. Larger studies with longer follow-up are needed.

  • Clinicopathological and Immunophenotypic Analysis of Early T‐Cell Precursor Acute Lymphoblastic Leukemia With Application of the Tokyo Children's Cancer Study Group Flow Cytometry Scoring System

    by Soundarya Ravi, Narasimhapriyan Kannan, Prabhu Manivannan, Rakhee Kar, Smita Kayal

    Introduction: Early T‐cell precursor acute lymphoblastic leukemia (ETP‐ALL) is a distinct subtype of T‐ALL defined by an immature immunophenotype and unique molecular features. It is often associated with chemoresistance and poor outcomes. Accurate recognition is crucial for therapy optimization and consideration of hematopoietic stem cell transplantation. This study evaluated the Tokyo Children's Cancer Study Group (TCCSG) six‐marker flow cytometric scoring system in identifying ETP‐ALL and assessed its clinicopathological features and treatment outcomes. Methods: All consecutive T‐ALL cases diagnosed between 2019 and 2023 were retrospectively analyzed. Clinical, immunophenotypic, and treatment‐related data were compared between ETP‐ALL and non‐ETP‐ALL subgroups. The TCCSG six‐marker scoring system (CD34, HLA‐DR, CD8, CD5, CD13, CD33) was applied, and receiver operating characteristic curve analysis determined the optimal cutoff for diagnosis. Results: Among 104 T‐ALL cases, 25 (24.1%) were classified as ETP‐ALL. ETP‐ALL was more common in adults (> 18 years; 72.0% vs. 48.1%; p = 0.037). Compared with non‐ETP‐ALL, patients showed lower leukocyte counts (< 100 × 10 9 /L), fewer peripheral blasts, and higher platelet counts ( p < 0.05). At end‐of‐induction (EOI), complete remission rates were lower in ETP‐ALL (73.3% vs. 96.6%; p = 0.014), though no significant differences were observed in EOI measurable residual disease, consolidation response, or survival between the groups. A cutoff score ≥ 3 using the TCCSG system yielded 88% sensitivity and 94.9% specificity (AUC = 0.986; p = 0.0001). Conclusion: ETP‐ALL represents a biologically distinct T‐ALL subtype with inferior early treatment responses. The TCCSG six‐marker scoring system is reliable, accurate, and practical for routine diagnosis, particularly in resource‐limited settings.

  • Open Access

    Titration of monoclonal antibodies and stability of tandem dyes in cocktail preparation for flow cytometry processing

    by Sherin Koodathil, Prabhu Manivannan

    Objectives: Tandem dyes are routinely used in multicolor flow cytometry (MFC) and consist of two fluorochromes, one donor and one acceptor. Antibody cocktails for various panels are prepared by combining the pre-titrated volumes of each fluorochrome-conjugated antibody. As the performance and stability of tandem dyes may deteriorate over time, this study aimed to optimize antibody titration volumes and assess the stability of pre-titrated tandem dyes in cocktail preparations. Materials and Methods: This was a quantitative study in which titration was performed, and the prepared antibody cocktail comprised cytoplasmic myeloperoxidase-Fluorescein Isothiocyanate (FITC), cytoplasmic cluster of differentiation (cCD) 79a-Phycoerythrin (PE), CD19-energy coupling dye (ECD), CD34-phycoerythrin-cyanin (PC) 5.5, cCD3-PC7, CD45-allophycocyanin (APC) 700, CD7-APC750, sCD3-pacific blue (PB), and human leucocyte antigen - D region related (HLA-DR isotype) tagged with krome orange (KO). CytoComp TM lyophilized cells were used to evaluate tandem dye stability daily for five days and weekly for four weeks. The stain-lyse-wash procedure was used, and data acquisition and analysis were performed in the Navios TM flow cytometer. Statistical analysis: The mean fluorescent intensity and percentage of positive cells were recorded for most of the antibodies in the cocktail. A coefficient of variation (CV) value of >5% was considered statistically significant, indicating the degradation of tandem dyes. Results: Antibody titration reduced the final antibody volume by 77%, reducing the cost per test. CV values remained below 5% during all assessments, confirming cocktail stability for up to four weeks when tested with lyophilized cells. Conclusions: The pre-titrated antibody cocktail was cost-effective and stable for up to four weeks, including tandem dyes, making it suitable for routine flow cytometric applications.

  • Mechanistic understanding of Wiskott–Aldrich syndrome protein (WASp)-mediated epigenetic regulation of T helper cell differentiation in acute leukemia

    by R. Pradeep, Sudeshna Rakshit, Geetha Shanmugam, Amit Choudhary, Ramya Ramesh, Jaikumar G. Ramamoorthy, Reena Gulati, Deepak Amalnath, Prabhu Manivannan, Smita Kayal, et al.

    Wiskott–Aldrich syndrome protein (WASp) is exclusively expressed in hematopoietic cells, yet its role in leukemia remains poorly defined. This study investigates the epigenetic regulation of key immune genes by T helper (TH) cell transcription factors. Human CD4⁺ T cells from healthy donors and patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) were transfected with control CRISPR (CO), WASp knockout (WKO), and WASp overexpression (WOE) plasmids. Flow cytometry confirmed intracellular WASp staining in CO, WKO, and WOE CD4⁺ T cells. WOE leads to elevated mRNA levels of TH1-associated transcription factors, such as TBX21 and IFNγ. Notably, TBX21 enrichment increased significantly in WOE cells, while no such enrichment was observed for GATA3, RORC, or FOXP3. In addition, aberrant accumulation of R-loops at key gene loci, including TBX21, STAT1, ATM, and H2AFX, was prominently observed in WKO cells but not in WOE conditions. DNA methylation increased WKO cells but m6A levels were elevated under WOE conditions. Immunofluorescence analysis revealed much higher WASp expression in WOE but increased γH2A.X fluorescence in WKO. We found WASp stably interacts with the STAT1 binding region in the TBX21 promoter by molecular docking studies. Nitric oxide, reactive oxygen species, and glutathione levels were higher in WKO cells, while lactate dehydrogenase levels were increased in WOE samples. These findings collectively imply that WOE in acute leukemia promotes TH1 cell activity in a significant manner through epigenetic regulation and could be a potential therapeutic target.

  • Open Access

    Comparison of single versus double platform analysis for CD34+ hematopoietic stem cell enumeration using International Society of Hematotherapy and Graft Engineering protocol and consensus among hematopathologists

    by Naadia Fatima Nadeem, M. Prabhu, Debdatta Basu, Rakhee Kar

    Objectives: The International Society of Hematotherapy and Graft Engineering (ISHAGE) provides guidelines for CD34+ hematopoietic stem cell (HSC) enumeration by flow cytometry (FCM) using two methods, namely single platform (SP) and double platform (DP). This study aimed to assess the degree of correlation and the level of agreement among hematopathologists between these methods. Material and Methods: This was a retrospective study in which patients undergoing HSC transplantation (HSCT) were included, and FCM enumeration was done on the pre-apheresis and post-apheresis product using SP and DP ISHAGE protocol. The list mode data files were re-analyzed by SP and compared with DP method for the degree of correlation; and the level of agreement among hematopathologists was assessed. Results: Totally, 78 patients underwent HSCT. The Spearman correlation for pre-apheresis and post-apheresis HSC was 0.919 (P = 0.0001) and 0.741 (P = 0.0002), indicating significant positive correlation between SP and DP and kappa coefficient of 0.234 and 0.252, respectively, indicating fair agreement among hematopathologists. The cost per test by the SP and DP was Rs. 1,950/- and Rs. 650/-, respectively. Conclusion: SP is recommended but more expensive while DP is cheaper and useful in cost-constrained setting. It is possible to achieve fair degree of agreement among hematopathologists.

  • Open Access

    Effect of internal audit-guided intervention on quality indicators in the processing and reporting of complete hemogram

    by E. Muhammed, Vishva Babu, Prabhu Manivannan, N. Sreekumaran Nair

    Objectives: The internationally accepted standard for clinical laboratories is an International Organization for Standardization 15189. In this study, we evaluated the effect of internal audit guided intervention on quality indicators in the processing and reporting of complete hemogram samples. Materials and Methods: We conducted the study in two phases and recruited 38,129 hemogram samples. We assessed five quality parameters and the results obtained (Phase I) were audited, appropriate interventions and amendments were done over the next 2 months. In the Phase II, the same quality parameters were analyzed and compared the results of Phases I and II. Statistical analysis: The continuous variables were compared using a paired “t”-test (Parametric variables). All statistical analyses were carried out at a 5% level of significance, with P < 0.05 considered statistically significant. Results: The sample rejection rate had substantially reduced by 54%. Internal quality control results showed significant improvement, and there was a substantial increase in critical value entries (nearly 3 times) in Phase II. However, the turn-around time was slightly increased in Phase II (173 min vs. 130 min). Overall, the internal audit guided intervention helped us in external quality assurance services by improving the z-score (standard score) for both accuracy and precision testing. Conclusions: This study improved our laboratory techniques, including quality control, and better documentation, and ensured the delivery of high-quality reports.


  • Open Access

    Lupus anticoagulant-hypoprothrombinemia syndrome presenting as bleeding diathesis – A study of two cases

    by Paruvathavarthini Thambiraj, Narasimhapriyan Kannan, Rakhee Kar, Prabhu Manivannan

    Lupus anticoagulant (LA)-hypoprothrombinemia syndrome is a combination of acquired factor II (FII) deficiency and LA. Herein, we report two young females presenting with a clinical history of menorrhagia, epistaxis, and gum bleeding with prolonged prothrombin time and activated partial thromboplastin time. The inhibitor screen suggested the presence of an immediate-acting inhibitor; tests for the presence of LA were positive. Factor assays performed showed low FII levels. Early diagnosis of this entity is crucial as it results in fatal complications due to bleeding.